Maximus, Inc. (NYSE:MMS) Expected to Post Q2 2024 Earnings of $1.33 Per Share

Maximus, Inc. (NYSE:MMSFree Report) – Research analysts at Zacks Research raised their Q2 2024 earnings per share (EPS) estimates for shares of Maximus in a note issued to investors on Tuesday, April 23rd. Zacks Research analyst R. Department now expects that the health services provider will earn $1.33 per share for the quarter, up from their previous forecast of $1.31. The consensus estimate for Maximus’ current full-year earnings is $5.41 per share. Zacks Research also issued estimates for Maximus’ Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.39 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.42 EPS and Q2 2026 earnings at $1.06 EPS.

MMS has been the subject of a number of other reports. Raymond James lowered Maximus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 3rd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 8th.

View Our Latest Analysis on Maximus

Maximus Stock Performance

NYSE MMS opened at $80.82 on Wednesday. The company’s fifty day moving average is $82.63 and its two-hundred day moving average is $81.30. Maximus has a 52-week low of $72.39 and a 52-week high of $89.69. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market capitalization of $4.93 billion, a price-to-earnings ratio of 26.76 and a beta of 0.72.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same period in the prior year, the business earned $0.94 earnings per share. Maximus’s revenue for the quarter was up 6.2% compared to the same quarter last year.

Institutional Trading of Maximus

Institutional investors have recently bought and sold shares of the business. Rise Advisors LLC raised its holdings in Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after purchasing an additional 289 shares during the period. VisionPoint Advisory Group LLC increased its position in shares of Maximus by 61.4% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock valued at $28,000 after buying an additional 145 shares in the last quarter. Anchor Investment Management LLC acquired a new stake in Maximus during the 4th quarter worth $32,000. Kapitalo Investimentos Ltda bought a new position in Maximus during the fourth quarter worth about $52,000. Finally, Planned Solutions Inc. bought a new position in Maximus during the fourth quarter worth about $59,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In other news, CFO David Mutryn sold 8,000 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the sale, the chief financial officer now owns 5,124 shares in the company, valued at $430,159.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.40% of the company’s stock.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.48%. Maximus’s dividend payout ratio is 39.74%.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Earnings History and Estimates for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.